Inicio › Trastorno depresivo mayor › Maryland
Ensayos clínicos de Trastorno depresivo mayor en Maryland
19 estudios sobre Trastorno depresivo mayor buscan participantes en Maryland.
Ciudades en Maryland
Texto oficial del estudio (inglés)
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Sunstone Medical, PC, Rockville
ReclutandoFase 3
Edades de 18 a 85 · Todos los sexos · Actualizado el 13 nov 2026 · NCT06793397Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
- National Institutes of Health Clinical Center, Bethesda
- University of Maryland, College Park, College Park
ReclutandoFase 2Se aceptan voluntarios sanos
Edades de 8 a 65 · Todos los sexos · Actualizado el 12 nov 2026 · NCT00018057Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1
Edades de 18 a 70 · Todos los sexos · Actualizado el 12 nov 2026 · NCT03973268Natural History of Depression, Bipolar Disorder and Suicide Risk
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacional
Edades de 18 a 120 · Todos los sexos · Actualizado el 9 nov 2026 · NCT06462196Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 1Se aceptan voluntarios sanos
Edades de 18 a 65 · Todos los sexos · Actualizado el 9 nov 2026 · NCT03065335A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07412756Defining Neurobiological Links Between Substance Use and Mental Illness
- National Institute on Drug Abuse, Baltimore
ReclutandoSe aceptan voluntarios sanos
Edades de 18 a 60 · Todos los sexos · Actualizado el 3 nov 2026 · NCT05538910A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Johns Hopkins University, Baltimore
ReclutandoFase 3
Edades de 12 a 17 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07227454A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Pharmasite Research, Inc., Baltimore
ReclutandoFase 3
Edades de 18 a 74 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07573176Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Gaithersburg
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06966401A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Clinical Research Site, Rockville
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT07621237Characterization and Treatment of Adolescent Depression
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 11 a 25 · Todos los sexos · Actualizado el 26 oct 2026 · NCT03388606Neurobiology of Suicide
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 2Se aceptan voluntarios sanos
Edades de 18 a 70 · Todos los sexos · Actualizado el 16 oct 2026 · NCT02543983Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Pikesville
ReclutandoFase 3
Edades de 18 a 65 · Todos los sexos · Actualizado el 13 oct 2026 · NCT07484217A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
- Draig Clinical Site, Gaithersburg
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 8 oct 2026 · NCT07300969NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
- National Institutes of Health Clinical Center, Bethesda
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 8 a 70 · Todos los sexos · Actualizado el 7 oct 2026 · NCT05669703Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression
- National Institutes of Health Clinical Center, Bethesda
ReclutandoFase 2
Edades de 18 a 70 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06511908A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Continental Clinical Solutions, Towson
ReclutandoFase 2
Edades de 18 a 64 · Todos los sexos · Actualizado el 27 jul 2026 · NCT07115329De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.